跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Subsyde-Cr - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Subsyde-Cr
Approved
STANDARD
Subsyde-Cr
Raptakos Brett & Co. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
afef9f7a157636b5
Company
Raptakos Brett & Co. Ltd.
Type
Standard
Approval Details
Approval Id
afef9f7a157636b5
Drug Approval Philippines Name
Subsyde-Cr
Product Name
Subsyde-Cr
Registration Number
DRP-1727
Brand Name
Subsyde-Cr
Generic Name
Diclofenac Sodium
Dosage Form
Controlled Release Capsule
Dosage Strength
100 mg
Manufacturer
Raptakos Brett & Co. Ltd.
Importer
Raptakos Brett & Co., Ltd
Distributor
Oxford Distributions, Inc.
Issuance Date
27 June 2022
Expiry Date
12 August 2027
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
afef9f7a157636b5
Type
Standard
Back to Philippines FDA Approvals